Similarly, oral cancer cells (CAL-27 & SCC-9 cell lines) treated with vitamin D showed a partial reversion of cisplatin resistance through lipocalin-2 (LCN2) protein downregulation [23]. This evidence concerns the gene LCN2 and lip and oral cavity carcinoma.